Health Populi

MARCH 11, 2021

[Note: I may be biased as a University of Michigan graduate of both the School of Public Health and Rackham School of Graduate Studies in Economics]. health care, patient assistance programs, Medicare Advantage plans, and the bundling of proven high-value preventive services into the Affordable Care Act.

Health Policy 245

Health Policy Medicare Pharmaceuticals Life Science 245

Health Populi

JANUARY 18, 2019

It is bittersweet to read the latter half of the title, as our friend and mentor Professor Reinhardt, a health economics pioneer, passed away last year. He co-wrote the first “It’s The Prices Stupid” research article in Health Affairs with Gerard Anderson et. Two news items illustrate this issue in real time.

BioTech 160

BioTech Medicare Medical Billing Patient Experience 160

Health Populi

MAY 8, 2019

In 2018, we saw more incentives to inspire adherence to prescription drug regimens, particularly in Medicare Part D along with increasing focus by pharmacists and providers. Just under 9% of patients across all three health plan types had over $500 in OOP costs in 2018. A cost of $125 or more yields abandonment of at least 50%.

Medicare 149

Medicare BioTech Pharmaceuticals Mental health 149

Health Populi

JUNE 18, 2020

The New England Journal of Medicine published an essay on June 4, 2020, titled, Specialty Drugs–A Distinctly American Phenomenon (my apologies–the article is behind the NEJM paywall). The phrase “specialty drugs” originated in the 1970s in the advent of injectable and infusion therapies.

BioTech 191

BioTech Medicare Life Science Telehealth 191

Health Populi

AUGUST 16, 2021

There is one health care public policy issue that unites U.S. Note in Exhibit 1 from the article the process and outcomes of UM programs for each of the stakeholders. voters across political party: that is the consumer-facing costs of prescription drugs. Every one of the processes generates a cost.

Pharmaceuticals 323

Pharmaceuticals Telehealth BioTech Mental health 323